Pharma Journalist -

Genmab A/S and CureVac AG announced that Genmab and CureVac have entered into a research collaboration and license agreement. This strategic partnership will focus on the research and…
Read More...

Achillion Pharmaceuticals announced that its shareholders have approved the acquisition of Achillion by Alexion Pharmaceuticals. Achillion continues to expect the transaction to close…
Read More...

Dicerna Pharmaceuticals, Inc. announced the successful closing of the research collaboration and licensing agreement between Dicerna and Roche following expiration of the waiting period…
Read More...

BC Platforms announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA. The round was led by IQVIA in conjunction with…
Read More...

Vaccitech Ltd announced that its strategic collaboration with the Ludwig Institute for Cancer Research (Ludwig), Vaccitech Oncology Limited (VOLT), has entered into a clinical…
Read More...

Global Blood Therapeutics, Inc. and Syros Pharmaceuticals, Inc. announced that they have entered into a collaboration to discover, develop and commercialize novel therapies for sickle…
Read More...

Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut Technology, have announced a…
Read More...

Dicerna Pharmaceuticals, Inc. announced that the European Commission (EC) has granted orphan drug designation to Dicerna’s DCR-A1AT for the treatment of congenital alpha-1 antitrypsin…
Read More...

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, and the Sean M.…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) voted 9-4 in favor…
Read More...